Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of Adenosine in Chronic Ischemic Cardiomyopathy
Role of IL-1-Beta on Adhesion Molecules in Myeloma
DNA Repair and Its Relationship to Carcinogenesis
Tobacco Products and Oral Cavity Cancer
U.S.-Switzerland Postdoctoral Exchange: Ion- and Laser-BeamInduced Metastable Phases
Recently added grants:
DNA damage signaling to immune checkpoints
Synergistic role of signaling and epigenetics in leukemic transformation
Transcriptional Regulatory Complexes in Epidermal Differentiation
Modeling multiple environmental exposures and childhood leukemia risk
A tethered capsule endoscopic-endomicroscopic (TEEM) approach for improving upper GI tract diagnosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35157-6-0-1
Application #
7575955
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Northwestern University at Chicago
$1,704,878
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bergan, Raymond C. /
$1,602,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant